EUVIMEDEUVIMED entdecken
Crossref

Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers

Noboru Hasegawa, Takayuki Ogino, Yuki Sekido, Mitsunobu Takeda, Tsuyoshi Hata, Atsushi Hamabe, Norikatsu Miyoshi, Mamoru Uemura, Hidetoshi Eguchi, Yuichiro Doki

Anticancer Research · 2026

DOI: 10.21873/anticanres.18098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Noboru Hasegawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Inflammatory Bowel Diseases, Antineoplastic Combined Chemotherapy Protocols, Crohn Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsInflammatory Bowel DiseasesAntineoplastic Combined Chemotherapy ProtocolsCrohn DiseaseColitis, UlcerativeHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedTreatment Outcome

Stichwörter der Autor:innen

Crohn’s disease-associated cancerInflammatory bowel diseasegastrointestinal cancerstreatment toxicity

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan togino04@gesurg.med.osaka-u.ac.jp.

Zitieren

APA

Hasegawa, N., Ogino, T., Sekido, Y., Takeda, M., Hata, T., Hamabe, A., Miyoshi, N., Uemura, M., Eguchi, H., & Doki, Y. (2026). Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers. Anticancer Research. https://doi.org/10.21873/anticanres.18098

Vancouver

Hasegawa N, Ogino T, Sekido Y, Takeda M, Hata T, Hamabe A, et al. Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers. Anticancer Research. 2026. doi:10.21873/anticanres.18098

BibTeX
@article{Hasegawa2026,
  author = {Hasegawa, Noboru and Ogino, Takayuki and Sekido, Yuki and Takeda, Mitsunobu and Hata, Tsuyoshi and Hamabe, Atsushi and Miyoshi, Norikatsu and Uemura, Mamoru and Eguchi, Hidetoshi and Doki, Yuichiro},
  title = {Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18098}
}
Kostenlos starten →